|
| | Publication Year | Title | Author(s) |
| 1 | 22-Feb-2023 | INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG). | Lam, Lyn Ley; Pavlakis, Nick; Shitara, Kohei; Sjoquist, Katrin M; Martin, Andrew J; Yip, Sonia; Kang, Yoon-Koo; Bang, Yung-Jue; Chen, Li-Tzong; Moehler, Markus; Bekaii-Saab, Tanios; Alcindor, Thierry; O'Callaghan, Christopher J ; Tebbutt, Niall C ; Hague, Wendy; Chan, Howard; Rha, Sun Young; Lee, Keun-Wook; Gebski, Val; Jaworski, Anthony; Zalcberg, John; Price, Timothy; Simes, John; Goldstein, David |
| 2 | Mar-2022 | The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours. | Foo, Tiffany; Goldstein, David; Segelov, Eva; Shapiro, Jeremy; Pavlakis, Nick; Desai, Jayesh; Yip, Desmond; Zalcberg, John; Price, Timothy J; Nagrial, Adnan; Chantrill, Lorraine; Burge, Matt; Karapetis, Christos S; Tebbutt, Niall C ; Roy, Amitesh C |
| 3 | Jan-2022 | Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty. | Nguyen, Mike ; Segelov, Eva; Goldstein, David; Pavlakis, Nick; Shapiro, Jeremy; Price, Timothy J; Nagrial, Adnan; Chantrill, Lorraine; Leong, Trevor; Chen, John; Burge, Matt; Karapetis, Christos S; Chau, Ian; Lordick, Florian; Renouf, Daniel; Tebbutt, Niall C ; Roy, Amitesh C |
| 4 | 5-Nov-2021 | Update on optimal management for pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty. | Nguyen, Mike ; Segelov, Eva; Goldstein, David; Pavlakis, Nick; Shapiro, Jeremy; Price, Timothy J; Nagrial, Adnan; Chantrill, Lorraine; Leong, Trevor; Chen, John; Burge, Matt; Karapetis, Christos S; Chau, Ian; Lordick, Florian; Renouf, Daniel; Tebbutt, Niall C ; Roy, Amitesh C |
| 5 | 18-Aug-2021 | MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG). | Siu, Ho Wai Derrick; Tebbutt, Niall C ; Chantrill, Lorraine; Karapetis, Chris; Steer, Christopher; Wilson, Kate; Espinoza, David; Bailey, Lisa; Yip, Sonia; Cuff, Jeff; Pavlakis, Nick; Thavaneswaran, Subotheni; Briscoe, Karen; Srivastav, Ratnesh; Shannon, Jennifer; Segelov, Eva; Tie, Jeannie; Caird, Susan; Francesconi, Alessandra; Price, Timothy; Wuttke, Melanie; Ladwa, Rahul; Sjoquist, Katrin; Burge, Matthew |
| 6 | 22-Feb-2021 | Rapid resistance of FGFR-driven gastric cancers to regorafenib and targeted FGFR inhibitors can be overcome by parallel inhibition of MEK. | Lau, David K ; Luk, Ian Y; Jenkins, Laura J; Martin, Andrew; Williams, David S ; Schoffer, Kael L; Chionh, Fiona; Buchert, Michael; Sjoquist, Katrin; Boussioutas, Alex; Hayes, Sarah A; Ernst, Matthias ; Weickhardt, Andrew J ; Pavlakis, Nick; Tebbutt, Niall C ; Mariadason, John M |
| 7 | 20-Apr-2020 | Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty. | Roy, Amitesh C; Shapiro, Jeremy; Burge, Matt; Karapetis, Christos S; Pavlakis, Nick; Segelov, Eva; Chau, Ian; Lordick, Florian; Chen, Li-Tong; Barbour, Andrew; Tebbutt, Niall C ; Price, Tim |
| 8 | Apr-2020 | Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO Congress 2019. | Lau, David K ; Burge, Matthew; Roy, Amitesh; Chau, Ian; Haller, Daniel G; Shapiro, Jeremy D; Peeters, Marc; Pavlakis, Nick; Karapetis, Christos S; Tebbutt, Niall C ; Segelov, Eva; Price, Timothy J |
Loading...
2
0
20
0
false